What are the sensitivity and specificity of CT pulmonary angiography (CTPA) for diagnosing pulmonary embolism (PE)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 11, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sensitivity and Specificity of CTPA for Pulmonary Embolism

CTPA is highly sensitive and specific for diagnosing pulmonary embolism, with sensitivity of 83% and specificity of 96% according to the most recent ACR guidelines, making it the first-line diagnostic imaging test for suspected PE. 1

Diagnostic Performance Characteristics

Overall Accuracy

  • Modern multidetector CTPA demonstrates sensitivities of 99-100% and specificities of 100% for detecting thromboembolic disease at the segmental level, representing the highest quality evidence for central and segmental PE detection 2
  • The ACR Appropriateness Criteria (2022) confirms CTPA is highly sensitive and specific, with the false-negative rate being very low 3
  • When combined with clinical assessment and D-dimer testing, CTPA achieves very high positive and negative predictive values 3

Performance by Vessel Size

  • CTPA reliably detects emboli down to 2-3 mm in subsegmental arteries, though accuracy decreases at the subsegmental level compared to more proximal vessels 3, 2
  • Interobserver agreement is good even with relatively inexperienced assessors, particularly to the segmental level 3
  • The main limitation compared to conventional angiography is reduced sensitivity for isolated subsegmental clot, though 94-96% of patients with subsegmental PE also have more proximal clot that can be reliably identified 3

Clinical Outcome Data (Most Important)

Safety of Negative CTPA

  • The negative predictive value is 96% for low clinical probability and 89% for intermediate probability, allowing clinicians to safely withhold anticoagulation after a negative study 1
  • Outcome studies demonstrate no adverse outcomes in patients with negative CTPA who were not subsequently treated 3
  • Three recent studies found subsequent PE in only 9 of 854 patients (1.1%) by 3 months after negative CTPA 3

Positive Predictive Value

  • A positive CTPA combined with high or intermediate clinical suspicion has high positive predictive value 3
  • The combination of CTPA with clinical probability assessment significantly enhances diagnostic accuracy 3

Technical Factors Affecting Accuracy

Optimal Performance Requirements

  • Slice thickness of 2-3 mm with reconstruction index of 2 mm is required for adequate segmental and subsegmental vessel analysis 2
  • Meticulous attention to technique, particularly contrast timing, is necessary to achieve published accuracy rates 3
  • A small proportion of examinations (up to 25% in some studies) may be technically inadequate 3
  • Multiplanar reformations and 3D renderings are essential components distinguishing CTPA from standard CT chest protocols 1, 2

Comparison to Historical Standards

Versus Conventional Pulmonary Angiography

  • The overall accuracy of catheter pulmonary angiography is likely inferior to CTPA due to technical factors including patient movement, vessel overlap, and inter/intraobserver variability 3
  • Even with subsegmental clot, conventional angiography shows interobserver disagreement in up to one-third of cases 3
  • Conventional angiography has estimated morbidity of 3.5-6% and mortality of 0.2-0.5% 3

Versus V/Q Scanning

  • CTPA is clearly superior in specificity to V/Q scanning 3
  • CTPA has fewer nondiagnostic studies than V/Q scans 3
  • Modern multidetector CTPA has achieved equivalent sensitivity of 99-100% to V/Q scanning for chronic thromboembolic disease 2

Important Clinical Caveats

Subsegmental PE Controversy

  • The clinical significance and need for treatment of isolated subsegmental PE remains controversial, as these very small clots may be of indeterminate clinical significance 3, 1
  • Only 1% of high-probability V/Q scans correspond to isolated subsegmental PE, compared with 15% of positive CTPA scans 3

Limitations and Contraindications

  • CTPA requires intravenous iodinated contrast, limiting use in patients with severe renal dysfunction or contrast allergies 1
  • Radiation dose is 3-10 mSv, which may be a consideration especially in young women due to breast tissue exposure 1
  • Technical adequacy requires patient cooperation for breath-holding and appropriate contrast bolus timing 3, 2

References

1
Guideline

Diagnosing Pulmonary Embolism with CTPA

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2
Guideline

Imaging for P3 Segment of the Pulmonary Artery

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the first line of diagnosis for a high-risk patient suspected of having a pulmonary embolism (PE), Computed Tomography (CT) chest scan or D-dimer test?
What type of imaging is recommended for the P3 segment of the pulmonary artery (PA)?
What is the recommended initial imaging test for suspected pulmonary embolism, specifically using Computed Tomography Pulmonary Angiography (CTPA)?
What is the best test for diagnosing pulmonary embolism (PE)?
What is the best imaging modality for diagnosing Pulmonary Embolism (PE)?
What are the signs and symptoms of bronchoaspiration, especially in vulnerable populations such as the elderly or those with significant comorbidities?
What should be looked for in a patient's antiphospholipid antibody panel (with a blue top tube) results, particularly those with a history of recurrent miscarriages or thrombotic events?
What does a mildly coarsened echotexture on a liver ultrasound indicate in a patient with risk factors for liver disease, such as hepatitis, alcohol abuse, or metabolic syndrome?
What withdrawal effects can occur when discontinuing Wellbutrin (bupropion)?
What are the differences between apixaban (direct oral anticoagulant) and heparin (anticoagulant) in patients with a history of thromboembolic events or atrial fibrillation, particularly in terms of dosing and bleeding risk in those with impaired renal function?
What is the best course of action for a patient finishing up bacterial vaginosis (BV) treatment who presents with urinary tract infection (UTI) symptoms, a normal urinalysis (UA) with ketonuria and trace hematuria, and pending urine culture and sexually transmitted infection (STI) testing?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question